Publications by authors named "Christopher Loo"

Claim this Profile
C
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 T cell responses.
Jillian M Jespersen J, Lia Avanesyan, Jean Publicover, Nicholas D Carey, Ravi K Patel, Christopher P Loo

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum.
Rashi Yadav, Morgan Vague, Malia Rettig, Christopher P Loo, Kasidy Brown

J Invest Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.
Isabella C Glitza, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Christopher P Loo

Cancer Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-12/IL23 blockade reveals patterns of asynchronous inflammation in pyoderma gangrenosum.
Rashi Yadav, Morgan Vague, Malia Rettig, Christopher P Loo, Kasidy Brown

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 T cells.
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Christopher P Loo

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin.
Ryan S Lane, Julia Femel, Alec P Breazeale, Christopher P Loo, Guillaume Thibault

J Exp Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection.
Christopher P Loo, Nicholas A Nelson, Ryan S Lane, Jamie L Booth, Sofia C Loprinzi Hardin

Cell Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells.
Christopher P Loo, Christopher M Snyder, Ann B Hill

J Immunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.
Iman K Yazdi, Matthew B Murphy, Christopher Loo, Xuewu Liu, Mauro Ferrari

J Tissue Eng· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines.
Charles M Lundquist, Christopher Loo, Ismail M Meraz, Jorge De La Cerda, Xuewu Liu

Med Sci (Basel)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.
Mingjun Wang, Bingnan Yin, Satoko Matsueda, Lijuan Deng, Ying Li, Christopher Loo

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.
Satoko Matsueda, Mingjun Wang, Jinsheng Weng, Ying Li, Bingnan Yin, Christopher Loo

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.
Jennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, Carlotta Kuylenstierna, Steven G Deeks

AIDS· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
Christopher P Loo, Brian R Long, Frederick M Hecht, Douglas F Nixon, Jakob Michaëlsson

AIDS Res Hum Retroviruses· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
Lishomwa C Ndhlovu, Christopher P Loo, Gerald Spotts, Douglas F Nixon, Frederick M Hecht

J Leukoc Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.
Brian R Long, Jakob Michaelsson, Christopher P Loo, Wassim M Ballan, Bien-Aimee N Vu

Clin Vaccine Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.
Jakob Michaëlsson, Brian R Long, Christopher P Loo, Lewis L Lanier, Gerald Spotts

J Infect Dis· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.
Wassim M Ballan, Bien-Aimee N Vu, Brian R Long, Christopher P Loo, Jakob Michaëlsson

J Immunol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
John W Northfield, Christopher P Loo, Jason D Barbour, Gerald Spotts, Frederick M Hecht

J Virol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.
Jennifer E Snyder-Cappione, Douglas F Nixon, Christopher P Loo, Joan M Chapman, Duncan A Meiklejohn

J Infect Dis· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
Fatema A Legrand, Douglas F Nixon, Christopher P Loo, Erika Ono, Joan M Chapman

PLoS One· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gold nanoshell bioconjugates for molecular imaging in living cells.
Christopher Loo, Leon Hirsch, Min-Ho Lee, Emmanuel Chang, Jennifer West

Opt Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotargeted nanoshells for integrated cancer imaging and therapy.
Christopher Loo, Amanda Lowery, Naomi Halas, Jennifer West, Rebekah Drezek

Nano Lett· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoshell-enabled photonics-based imaging and therapy of cancer.
Christopher Loo, Alex Lin, Leon Hirsch, Min-Ho Lee, Jennifer Barton

Technol Cancer Res Treat· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases.
Taro Amagata, Stephanie Whitman, Tyler A Johnson, Chad C Stessman, Christopher P Loo

J Nat Prod· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis